Biotech · Private company
Nuventra, Inc.
Track this companyFree. Adds Nuventra, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and TransportPHASE1 · COMPLETED · started Apr 26, 2022ClinicalTrials.gov NCT05334108 · fetched Nov 12, 2026
- Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetabolitePHASE1 · COMPLETED · started May 13, 2021ClinicalTrials.gov NCT04902105 · fetched Nov 12, 2026
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple SubstratesPHASE1 · TERMINATED · started Feb 18, 2021ClinicalTrials.gov NCT04764851 · fetched Nov 12, 2026
- Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of TreprostinilPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 18, 2019ClinicalTrials.gov NCT03992755 · fetched Nov 12, 2026
- Investigation of the Safety and Pharmacology of Dry Powder Inhalation of TreprostinilPHASE3 · COMPLETED · started Jan 2, 2018ClinicalTrials.gov NCT03399604 · fetched Nov 12, 2026